Clinical features and molecular analysis of acquired hemoglobin H disease, Am J Med, vol.75, pp.181-191, 1983. ,
Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS), Nat Genet, vol.34, pp.446-449, 2003. ,
ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a sizedependent manner, Cell, vol.143, pp.367-378, 2010. ,
Acquired somatic ATRX mutations in myelodysplastic syndrome associated with alpha thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations, Blood, vol.103, pp.2019-2026, 2004. ,
Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies, Blood, vol.105, pp.443-452, 2005. ,
Clinical and biological implications of driver mutations in myelodysplastic syndromes, Blood, vol.122, pp.3616-3627, 2013. ,
A new ATRX mutation in a patient with acquired athalassemia myelodysplastic syndrome, Hemoglobin, vol.36, pp.581-585, 2012. ,
Acquired alpha thalassemia myelodyslastic/myeloproliferative syndrome (ATMDS): Evolution on hypomethylating agent therapy, Leuk Res, vol.35, pp.203-205, 2011. ,